Literature DB >> 16978244

Saliva can mediate HIV-1-specific antibody-dependent cell-mediated cytotoxicity.

Jenney S Kim1, Pratip Nag, Alan L Landay, Mario Alves, Mardge H Cohn, James W Bremer, Linda L Baum.   

Abstract

HIV is not usually transmitted by saliva from HIV-1-infected individuals. Antiviral substances in saliva responsible for this may include HIV-1-specific antibody-dependent cell-mediated cytotoxicity (ADCC). We evaluated saliva ADCC titers of 62 HIV-1-infected women from the Women's Interagency HIV Study (WIHS) and 55 uninfected individuals. HIV-1-infected women were less likely to have ADCC activity in saliva than in serum or cervical lavage fluid (CVL). 24% of HIV-1-positive women and a similar percentage of uninfected women had HIV-1-specific saliva ADCC activity. A significant amount of saliva ADCC activity in infected women was HIV-gp120-specific. These studies demonstrate that HIV-specific ADCC activity can be present in saliva. This activity may contribute to host defence against initial infection with HIV.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16978244     DOI: 10.1111/j.1574-695X.2006.00146.x

Source DB:  PubMed          Journal:  FEMS Immunol Med Microbiol        ISSN: 0928-8244


  4 in total

1.  Comparison of the immune microenvironment of the oral cavity and cervix in healthy women.

Authors:  Carole Fakhry; Morgan A Marks; Robert H Gilman; Lilia Cabrerra; Pablo Yori; Margaret Kosek; Patti E Gravitt
Journal:  Cytokine       Date:  2013-09-07       Impact factor: 3.861

2.  Robust NK cell-mediated human immunodeficiency virus (HIV)-specific antibody-dependent responses in HIV-infected subjects.

Authors:  Ivan Stratov; Amy Chung; Stephen J Kent
Journal:  J Virol       Date:  2008-03-19       Impact factor: 5.103

3.  Mucosal immunity to HIV: a review of recent literature.

Authors:  Barbara L Shacklett
Journal:  Curr Opin HIV AIDS       Date:  2008-09       Impact factor: 4.283

Review 4.  Oral infectious diseases: a potential risk factor for HIV virus recrudescence?

Authors:  O A González; J L Ebersole; C B Huang
Journal:  Oral Dis       Date:  2009-04-02       Impact factor: 3.511

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.